ADMA Biologics Inc (NASDAQ:ADMA)

9.15
Delayed Data
As of Apr 17
 +0.02 / +0.22%
Today’s Change
6.76
Today|||52-Week Range
14.00
-18.08%
Year-to-Date
No recent news for ADMA Biologics Inc.

Today’s Trading

Previous close9.13
Today’s open9.19
Day’s range9.02 - 9.19
Volume1,525
Average volume (3 months)21,277
Market cap$97.9M
Dividend yield--
Data as of 3:16pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+23.95%
Earnings growth (this year)-11.49%
Earnings growth (next 5 years)--
Revenue growth (last year)+92.84%
P/E ratioNM
Price/Sales17.55
Price/Book14.15

Competitors

 Today’s
change
Today’s
% change
TENXTenax Therapeutics I...+0.02+0.58%
ORPNBio Blast Pharma Ltd-0.26-3.86%
PIPPharmAthene Inc-0.07-4.09%
--ImmunoClin Corp-2.40-44.44%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$5.9M
Annual profit (last year)-$16.8M
Net profit margin-284.22%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Adam S. Grossman
Chief Financial Officer &
Vice President
Brian Lenz
Corporate headquarters
Ramsey, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers